Fig. 1.
PSA-PFS (a), local PFS (b), distant PFS (c) and time to initiation of ADT or time to intensification of systemic therapy (d), after SBRT of osseous oligometastases of PC patients
PSA-PFS (a), local PFS (b), distant PFS (c) and time to initiation of ADT or time to intensification of systemic therapy (d), after SBRT of osseous oligometastases of PC patients